Cell Therapeutics Seeks Two NDAs in 2009

Biopharmaceutical company Cell Therapeutics, Inc., in a review of its 2009 targeted milestones and 2008 accomplishments, announced that it is seeking to obtain two new drug approvals, or NDAs, in 2009, besides the potential label expansion for lymphoma drug Zevalin.
RTTNews